Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Gains from Investment Securities (2016 - 2025)

Corcept Therapeutics (CORT) has disclosed Gains from Investment Securities for 12 consecutive years, with -$23.4 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 435.49% to -$23.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, down 79.59% year-over-year, with the annual reading at $13.0 million for FY2025, 41.85% down from the prior year.
  • Gains from Investment Securities hit -$23.4 million in Q4 2025 for Corcept Therapeutics, down from $4.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $16.4 million in Q1 2021 to a low of -$23.4 million in Q4 2025.
  • Historically, Gains from Investment Securities has averaged $3.8 million across 5 years, with a median of $2.4 million in 2021.
  • Biggest five-year swings in Gains from Investment Securities: soared 1500.0% in 2021 and later plummeted 435.49% in 2025.
  • Year by year, Gains from Investment Securities stood at $2.5 million in 2021, then plummeted by 66.38% to $846000.0 in 2022, then rose by 17.61% to $995000.0 in 2023, then skyrocketed by 602.01% to $7.0 million in 2024, then tumbled by 435.49% to -$23.4 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CORT at -$23.4 million in Q4 2025, $4.1 million in Q3 2025, and $7.6 million in Q2 2025.